Hepatitis C.

LDR 01004cam a2200289Ia 4500
001 011399381
003 MiAaHDL
005 20141009010000.0
006 m d
007 cr bn ---auaua
008 000731s2000 mdu f000 0 eng d
035 ‡asdr-uiuc4267251
035 ‡9DYZ-6412
035 ‡a(OCoLC)44687234
040 ‡aFDA ‡cFDA
049 ‡aIADA
074 ‡a0467-A-35
086 0 ‡aHE 20.3971:H 41 ‡zHE 20.3952:D 84/2000
245 0 0 ‡aHepatitis C.
260 ‡aBethesda, MD (6001 Executive Blvd., Bethesda 20892) : ‡bNational Institute on Drug Abuse, U.S. Dept. of Health and Human Services, National Institutes of Health, ‡c[2000]
300 ‡a[4] p. ; ‡c28 cm.
490 0 ‡aNIH publication. ; ‡vno. 00-4663
490 0 ‡aCommunity drug alert bulletin
500 ‡aShipping list no.: 2000-0272-P.
500 ‡a"May 2000."
500 ‡aCaption title.
504 ‡aIncludes bibliographical references (p. [4]).
538 ‡aMode of access: Internet.
650 0 ‡aHepatitis C.
710 2 ‡aNational Institute on Drug Abuse.
CID ‡a011399381
DAT 0 ‡a20020415165525.0 ‡b20141009010000.0
DAT 1 ‡a20141112162027.0 ‡b2023-03-13T18:20:28Z
CAT ‡aSDR-UIUC ‡dUNKNOWN ‡lloader.pl-003-020
FMT ‡aBK
HOL ‡0sdr-uiuc4267251 ‡auiug ‡bSDR ‡cUIUC ‡puiug.30112104067845 ‡sUIU ‡14267251
974 ‡bUIU ‡cUIUC ‡d20230313 ‡sgoogle ‡uuiug.30112104067845 ‡y2000 ‡rpd ‡qbib ‡tUS fed doc